The role of theragnostics in oncology: an interview with Stefano Buono

• Published in: International journal of endocrine oncology Vol. 4; no. 3; pp. 121 - 125
• Main Author: Buono, Stefano
• Format: Journal Article
• Language: English
• Published: London Future Medicine Ltd 01.08.2017
• Subjects: Breast cancer; Cancer therapies; Clinical trials; Drugs; Isotopes; Ligands; NETs; Neuroendocrine tumors; Nuclear medicine; Oncology; Patients; Peptides; Prostate cancer; theragnostics; United States > US

Stefano Buono is the Chief Executive Officer, a member of the board of directors, and a founder of Advanced Accelerator Applications (AAA). He has been responsible for overseeing AAA operations, including the development and commercialization of the current portfolio of diagnostic and therapeutic mo...